Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[14C]CS0159 in Chinese Healthy Subjects for Mass Balance Phase I Study

NCT06098027 is registered in ClinicalTrials.gov with Cascade Pharmaceuticals, Inc as lead sponsor.

NCT NCT06098027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06098027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[14C]CS0159 in Chinese Healthy Subjects for Mass Balance Phase I Study
Lead sponsor
Cascade Pharmaceuticals, Inc
Phase
Phase 1
Overall status
Completed
Start date
October 23, 2023
Completion date
November 2, 2023
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary biliary cholangitis